.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Medtronic
Covington
Argus Health
Baxter
Queensland Health
Cipla
Merck
Johnson and Johnson
Boehringer Ingelheim

Generated: July 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074921

« Back to Dashboard
NDA 074921 describes ESTAZOLAM, which is a drug marketed by Watson Labs, Mayne Pharma, and Par Pharm, and is included in three NDAs. It is available from five suppliers. Additional details are available on the ESTAZOLAM profile page.

The generic ingredient in ESTAZOLAM is estazolam. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the estazolam profile page.

Summary for NDA: 074921

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 074921

Ingredient-typeBenzodiazepines

Suppliers and Packaging for NDA: 074921

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ESTAZOLAM
estazolam
TABLET;ORAL 074921 ANDA Teva Pharmaceuticals USA, Inc. 0093-0129 0093-0129-01 100 TABLET in 1 BOTTLE (0093-0129-01)
ESTAZOLAM
estazolam
TABLET;ORAL 074921 ANDA Teva Pharmaceuticals USA, Inc. 0093-0130 0093-0130-01 100 TABLET in 1 BOTTLE (0093-0130-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Jul 10, 1997TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Jul 10, 1997TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
Harvard Business School
Covington
Mallinckrodt
Novartis
US Department of Justice
Argus Health
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot